MIRA Pharmaceuticals (MIRA) Institutional Ownership → get a piece of the profit from this land (From True Market Insiders) (Ad) Free MIRA Stock Alerts $0.66 -0.02 (-2.96%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for MIRA Pharmaceuticals (NASDAQ:MIRA)CurrentInstitutional OwnershipPercentage35.16%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$495.99KNumber ofInstitutional Sellers(last 12 months)0 Get MIRA Insider Trade Alerts Want to know when executives and insiders are buying or selling MIRA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. MIRA Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/2/2024 Suncoast Equity Management40,000$44K0.0%N/A0.271% 5/2/2024 Cross Staff Investments Inc383,401$422K0.4%N/A2.594% 4/10/2024 Praetorian Wealth Management Inc.27,500$30K0.0%N/A0.186% (Data available from 1/1/2016 forward) MIRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MIRA shares? During the previous two years, the following institutional investors and hedge funds held shares of MIRA Pharmaceuticals shares: Cross Staff Investments Inc ($422K), and Suncoast Equity Management ($44K), Praetorian Wealth Management Inc. ($30K).Learn more on MIRA's institutional investors. What percentage of MIRA Pharmaceuticals stock is owned by institutional investors? 35.16% of MIRA Pharmaceuticals stock is owned by institutional investors. Learn more on MIRA's institutional investor holdings. Which institutional investors have been buying MIRA Pharmaceuticals stock? The following institutional investors have purchased MIRA Pharmaceuticals stock in the last 24 months: Cross Staff Investments Inc ($383.40K), Suncoast Equity Management ($40K), and Praetorian Wealth Management Inc. ($27.50K). How much institutional buying is happening at MIRA Pharmaceuticals? Institutional investors have bought a total of 450,901 shares in the last 24 months. This purchase volume represents approximately $495.99K in transactions. Related Companies: Monopar Therapeutics Institutional Ownership Galera Therapeutics Institutional Ownership Avalo Therapeutics Institutional Ownership Elevai Labs Institutional Ownership Moleculin Biotech Institutional Ownership ABVC BioPharma Institutional Ownership Molecular Templates Institutional Ownership Addex Therapeutics Institutional Ownership Eterna Therapeutics Institutional Ownership Akari Therapeutics Institutional Ownership This page (NASDAQ:MIRA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.